cb-012
caribou
['cb-012', 'cll', 'caribou']
$crbu caribou biosciences presents new preclinical data on cb-012, an allogeneic anti-cll-1 car-t cell therapy, at the 2023 aacr annual meeting 
Stay ahead of the market with ultra-fast stock news updates. 
FREE with 15 sec delay. Upgrade to Gold for even faster news & exclusive features @ https://t.co/LViEqnfZ7i